Molecular Characterization and Spatiotemporal Evidence Synthesis of Antimalarial Drug Resistance Markers in Plasmodium Falciparum Isolates from Southeastern Nigeria

Malaria remains a major public health challenge in Nigeria, and antimalarial drug resistance continues to threaten treatment efficacy and malaria control. This revised manuscript explicitly defines the work as a retrospective evidence synthesis of published molecular studies, supported by a proposed multi-centre surveillance framework for Southeastern Nigeria rather than as a primary laboratory investigation. Published evidence from Southeast and adjacent southern Nigerian sentinel sites was reviewed to describe molecular markers associated with chloroquine, sulfadoxine-pyrimethamine (SP), and artemisinin-based combination therapy resistance in Plasmodium falciparum. The synthesis focused on pfcrt, pfmdr1, pfdhfr, pfdhps, and pfk13/k13 markers, with particular attention to their spatial distribution, temporal relevance, and implications for national malaria treatment policy. Extracted findings showed persistent high prevalence of pfcrt 76T in Anambra/Nnewi isolates, near-fixation of pfdhfr triple-mutant markers in antenatal populations, high frequencies of pfdhps A437G and A613S/A581G in southern Nigeria, and the regional emergence of pfdhps I431V, including a high signal in Enugu. Validated artemisinin-resistance pfk13 mutations have not been widely reported from Southeastern Nigeria, but regional evidence from Africa demonstrates the need for early warning surveillance. The revised methods provide clear eligibility criteria, data extraction procedures, sample size guidance for future primary surveillance, laboratory quality assurance measures, sequencing options, statistical analysis approaches, GIS mapping procedures, and ethical considerations. The findings support intensified molecular surveillance integrated with Nigeria’s National Malaria Elimination Programme to guide ACT efficacy monitoring, IPTp-SP policy review, and targeted resistance containment.

Plasmodium falciparum; antimalarial drug resistance; molecular surveillance; pfcrt

1. Adegbola, A. J., Adegbola, R. A., & others. (2023). A snapshot of the prevalence of dihydropteroate synthase mutations in Plasmodium falciparum in Nigeria. Malaria Journal, 22, 75. https://doi.org/10.1186/s12936-023-04487-5 [Google Scholar] [Crossref]

2. Bamikole, O. J., Fayehun, A. F., Uthman, Y. A., Salako, I. A., Adedeji, B. A., Olufeagba, M.-D. B., & Amodu, O. K. (2025). Molecular surveillance of antimalarial drug resistance genes in Nigeria: A systematic review and roadmap to malaria elimination. BMC Medical Genomics, 18, 195. https://doi.org/10.1186/s12920-025-02246-w [Google Scholar] [Crossref]

3. Dhorda, M., Kaneko, A., Komatsu, R., Kc, A., Mshamu, S., Gesase, S., Kapologwe, N., Assefa, A., Opigo, J., Adoke, Y., Ebong, C., Karema, C., Uwimana, A., Mangara, J.-L. N., Amaratunga, C., Peto, T. J., Tripura, R., Callery, J. J., Adhikari, B., ... von Seidlein, L. (2024). Artemisinin-resistant malaria in Africa demands urgent action. Science, 385(6706), 252-254. https://doi.org/10.1126/science.adp5137 [Google Scholar] [Crossref]

4. Esu, E., Tacoli, C., Gai, P. P., Berens-Riha, N., Pritsch, M., Loescher, T., & Meremikwu, M. (2018). Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria. Parasitology Research, 117(3), 801-807. https://doi.org/10.1007/s00436-018-5754-5 [Google Scholar] [Crossref]

5. Ikegbunam, M. N., Nkonganyi, C. N., Thomas, B. N., Esimone, C. O., Velavan, T. P., & Ojurongbe, O. (2019). Analysis of Plasmodium falciparum Pfcrt and Pfmdr1 genes in parasite isolates from asymptomatic individuals in Southeast Nigeria 11 years after withdrawal of chloroquine. Malaria Journal, 18, 343. https://doi.org/10.1186/s12936-019-2977-6 [Google Scholar] [Crossref]

6. Kojom Foko, L. P., & Sharma, A. (2026). Artemisinin resistance threat in Central and West Africa needs holistic action. Journal of Public Health in Africa, 17(1), a1405. https://doi.org/10.4102/jphia.v17i1.1405 [Google Scholar] [Crossref]

7. Naidoo, I., & Roper, C. (2013). Mapping “partially resistant”, “fully resistant”, and “super resistant” malaria. Trends in Parasitology, 29(10), 505-515. https://doi.org/10.1016/j.pt.2013.08.002 [Google Scholar] [Crossref]

8. National Malaria Elimination Programme. (2021). National Malaria Strategic Plan 2021-2025. Federal Ministry of Health, Nigeria. [Google Scholar] [Crossref]

9. Oguike, M. C., Falade, C. O., Shu, E., Enato, I. G., Watila, I., Baba, E. S., Bruce, J., Webster, J., Hamade, P., Meek, S., Chandramohan, D., Sutherland, C. J., Warhurst, D., & Roper, C. (2016). Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V. International Journal for Parasitology: Drugs and Drug Resistance, 6(3), 220-229. https://doi.org/10.1016/j.ijpddr.2016.08.004 [Google Scholar] [Crossref]

10. World Health Organization. (2024). World malaria report 2024. World Health Organization. [Google Scholar] [Crossref]

11. World Health Organization. (2025a). Malaria: Artemisinin partial resistance. World Health Organization. [Google Scholar] [Crossref]

12. World Health Organization. (2025b). Compendium of molecular markers for antimalarial drug resistance. World Health Organization. [Google Scholar] [Crossref]

• Tribal Child Nutrition and Health in District of Sundargarh: A Public Health Review of ICDS Intervention
• Knowledge, Attitudes and Practices Towards Prostate Cancer Screening Amongst Men Aged 40-60 Years in The Buea Health District: A Cross-Sectional Study
• Compliance with JCI Protocols: A Focus on Employee Safety
• Influence and Involvement of Teachers in Menstrual Hygiene Management of Female Secondary School Students in Kogi State, Nigeria
• A Critical Evaluation of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana in Bihar